Literature DB >> 3063777

Methylprednisolone in multiple sclerosis: a comparative dose study.

L Bindoff, P R Lyons, P K Newman, M Saunders.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3063777      PMCID： PMC1033131          DOI： 10.1136/jnnp.51.8.1108

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  12 in total

1.  FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS.

Authors:  J F KURTZKE
Journal:  Neurology       Date:  1965-07       Impact factor: 9.910

2.  Repetitive discharges in human motor nerve fibers during the post-ischaemic state.

Authors:  E KUGELBERG; W COBB
Journal:  J Neurol Neurosurg Psychiatry       Date:  1951-05       Impact factor: 10.154

3.  Intravenous methylprednisolone for multiple sclerosis in relapse.

Authors:  M P Barnes; D E Bateman; P G Cleland; D J Dick; T J Walls; P K Newman; M Saunders; P J Tilley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-02       Impact factor: 10.154

4.  Generalized muscular stiffness, fasciculations, and myokymia of peripheral nerve origin.

Authors:  W E Wallis; A Van Poznak; F Plum
Journal:  Arch Neurol       Date:  1970-05

5.  Treatment of acute exacerbations of multiple sclerosis with intravenous methyl-prednisolone.

Authors:  C Buckley; C Kennard; M Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-02       Impact factor: 10.154

6.  The origin of fasciculations.

Authors:  G Roth
Journal:  Ann Neurol       Date:  1982-12       Impact factor: 10.422

7.  Hyperexcitability of motor and sensory neurons in neuromyotonia.

Authors:  J W Lance; D Burke; J Pollard
Journal:  Ann Neurol       Date:  1979-06       Impact factor: 10.422

8.  High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations.

Authors:  L Durelli; D Cocito; A Riccio; C Barile; B Bergamasco; G F Baggio; F Perla; M Delsedime; G Gusmaroli; L Bergamini
Journal:  Neurology       Date:  1986-02       Impact factor: 9.910

9.  A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.

Authors:  N M Milligan; R Newcombe; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-05       Impact factor: 10.154

10.  "Bolus" methylprednisolone versus ACTH in the treatment of multiple sclerosis.

Authors:  G Abbruzzese; C Gandolfo; C Loeb
Journal:  Ital J Neurol Sci       Date:  1983-06
View more
  3 in total

1.  A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy.

Authors:  Pietro Annovazzi; Valentina Tomassini; Benedetta Bodini; Laura Boffa; Massimiliano Calabrese; Eleonora Cocco; Cinzia Cordioli; Giovanna De Luca; Giovanni Frisullo; Antonio Gallo; Simona Malucchi; Damiano Paolicelli; Ilaria Pesci; Marta Radaelli; Paolo Ragonese; Luca Roccatagliata; Carla Tortorella; Marco Vercellino; Valentina Zipoli; Claudio Gasperini; Mariaemma Rodegher; Claudio Solaro
Journal:  Neurol Sci       Date:  2012-03-11       Impact factor: 3.307

2.  Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose.

Authors:  S M Alam; T Kyriakides; M Lawden; P K Newman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-11       Impact factor: 10.154

Review 3.  Multiple sclerosis therapy. A practical guide.

Authors:  B W van Oosten; L Truyen; F Barkhof; C H Polman
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.